Literature DB >> 11479207

Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.

S Toyooka1, H I Pass, N Shivapurkar, Y Fukuyama, R Maruyama, K O Toyooka, M Gilcrease, A Farinas, J D Minna, A F Gazdar.   

Abstract

Aberrant promoter methylation and resultant silencing of several genes plays an important role in the pathogenesis of many tumor types. We compared the methylation profile of 66 malignant mesotheliomas (MMs) and 40 lung adenocarcinomas using methylation-specific PCR for seven genes frequently methylated in lung cancer. We also compared the methylation frequencies of these genes as well as the methylation index, a reflection of all of the gene frequencies, with the presence of SV40 large T-antigen (Tag) sequences, histological subtype, and patient survival. Our major findings are: (a) with the exception of the RASSF1A promoter of the RASSF1 gene, frequencies of aberrant methylation were significantly lower in MMs than in adenocarcinomas; (b) the frequency of RASSF1A aberrant methylation and the value of the methylation index were significantly higher in SV40 sequence positive MM than in negative MM; and (c) the methylation index was higher in epithelial MM than in sarcomatous/mixed MM. Our results demonstrate a relationship between SV40 and aberrant methylation in MMs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479207

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.

Authors:  Masanori Fujii; Nobukazu Fujimoto; Akio Hiraki; Kenichi Gemba; Keisuke Aoe; Shigeki Umemura; Hideki Katayama; Nagio Takigawa; Katsuyuki Kiura; Mitsune Tanimoto; Takumi Kishimoto
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

2.  DNA copy number gains in malignant pleural mesothelioma.

Authors:  Masashi Furukawa; Shinichi Toyooka; Tatsuro Hayashi; Hiromasa Yamamoto; Nobukazu Fujimoto; Junichi Soh; Shinsuke Hashida; Kazuhiko Shien; Hiroaki Asano; Keisuke Aoe; Kazunori Okabe; Harvey I Pass; Kazunori Tsukuda; Takumi Kishimoto; Shinichiro Miyoshi
Journal:  Oncol Lett       Date:  2015-08-27       Impact factor: 2.967

Review 3.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways.

Authors:  Haiqun Lin; Ziding Feng; Yan Yu; Yingye Zheng; Narayan Shivapurkar; Adi F Gazdar
Journal:  J Am Stat Assoc       Date:  2008-03-01       Impact factor: 5.033

5.  Genetic and epigenetic tumor suppressor gene silencing are distinct molecular phenotypes driven by growth promoting mutations in nonsmall cell lung cancer.

Authors:  Carmen J Marsit; E Andres Houseman; Heather H Nelson; Karl T Kelsey
Journal:  J Cancer Epidemiol       Date:  2009-01-28

6.  Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

Authors:  Sun Lee; Hyeon Joo Lee; Jae-Hoon Kim; Hyo-Suk Lee; Ja June Jang; Gyeong Hoon Kang
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Preformed hexamers of SV40 T antigen are active in RNA and origin-DNA unwinding.

Authors:  Heike Uhlmann-Schiffler; Stephanie Seinsoth; Hans Stahl
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

8.  Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.

Authors:  Brock C Christensen; Carmen J Marsit; E Andres Houseman; John J Godleski; Jennifer L Longacker; Shichun Zheng; Ru-Fang Yeh; Margaret R Wrensch; Joseph L Wiemels; Margaret R Karagas; Raphael Bueno; David J Sugarbaker; Heather H Nelson; John K Wiencke; Karl T Kelsey
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

9.  Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri.

Authors:  Na Rae Kim; Zhenhua Lin; Kyong Rae Kim; Hyun Yee Cho; Insun Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

10.  EGFR and KRAS mutations in patients with adenocarcinoma of the lung.

Authors:  Tae Won Jang; Chul Ho Oak; Hee Kyung Chang; Soon Jung Suo; Mann Hong Jung
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.